Market Overview:
The global naloxone market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidences of opioid overdose, increasing awareness about preventing opioid abuse, and growing demand for naloxone spray forms. However, the high cost of naloxone products is expected to restrain the growth of the market during the forecast period. On basis on type, injectable forms are expected to account for a larger share in terms of revenue in 2018 as compared to spray forms. However, over next few years (2018-2030), spray form is projected register highest CAGR due its easy availability and low cost as compared with injectable form. On basis on application, opioid overdose segment accounted for majority share in 2017 and it is projected continue dominate throughout forecast period owing rising incidences rates across globe coupled with increasing number emergency medical services (EMS) that carry antidote kits containing naloxone injection or nasal sprays specifically designed for reversing an opiate overdose.
Product Definition:
Naloxone is a drug that blocks the effects of opioids and can reverse an overdose. It is important because it can save lives by reversing the effects of an opioid overdose.
Spray forms:
Spray forms are a new delivery system for the drug in its liquid form. It is an aerosolized solution of the drug which can be administered through spray, nasal, or by injection. The product has been designed to reduce the abuse and misuse of opioid medication which is helpful in curbing addiction to opioids.
Injectable forms:
Injectable forms are the most commonly used opioid overdose reversal drug. It is a form of buprenorphine that is administered by injection into muscle, usually the outer thigh. The drug works quickly and has an effect similar to that of an opioid like morphine, but it has much lower potency than morphine and can be used in people who are physically resistant to naloxone.
The injectable form of naloxone was approved by the U.
Application Insights:
The global naloxone market is segmented based on application into opioid overdose, preventing opioid abuse and other applications. In 2017, the opioid overdose application dominated the market with a share of over 80% in terms of revenue. The high share is attributable to increasing number of drug overdoses across the globe which has resulted in growing demand for naloxone hydrochloride injection by healthcare professionals and laypersons alike.
Naloxone hydrochloride injection is an effective treatment for reversing heroin, prescription painkiller and methadone overdoes as well as can be used to prevent such incidents from occurring in the first place. Thus, prevention of opioid abuse also accounted for a significant share in 2017 owing to awareness programs conducted by various governments around the world including U.S.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of opioid-based drug formulations in U.S. The country also witnessed an increase in naloxone distribution through various public health programs and initiatives by government and non-government organizations. For instance, the National Association of Drug Diversionists (NADD) distributes free naloxone kits to any organization that requests for it along with providing education about its proper use.
Asia Pacific is expected to register significant growth over the forecast period due to growing awareness among people regarding opioid addiction coupled with rising incidence rates of substance abuse disorders, especially among youth and young adults aged 18’30 years old group across countries such as China, India, Japan, Malaysia & Singapore etc., which is anticipated boost product demand during this period. Moreover, increasing cases of fatal overdoses are also expected drive regional growth over next eight years (2030).
Growth Factors:
- Increasing incidences of opioid overdose: The increasing incidence of opioid overdose is one of the key growth drivers for the naloxone market. According to a study by the National Institute on Drug Abuse, in 2015, around 33,091 people died due to an opioid overdose in the U.S., which was a record high. This number is expected to rise in the coming years owing to the increasing abuse of opioids such as heroin and fentanyl.
- Growing awareness about naloxone: The growing awareness about naloxone among healthcare professionals and general population is another major growth driver for this market. Naloxone can reverse an opioid overdose within minutes and hence can save lives if administered timely. This has led to an increase in its demand over past few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Naloxone Market Research Report
By Type
Spray forms, Injectable forms
By Application
Opioid overdose, Preventing opioid abuse
By Companies
ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals, Mylan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Naloxone Market Report Segments:
The global Naloxone market is segmented on the basis of:
Types
Spray forms, Injectable forms
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Opioid overdose, Preventing opioid abuse
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ADAPT Pharma
- Amphastar Pharmaceuticals
- Pfizer
- kaleo
- Sandoz
- Amneal Pharmaceuticals
- West Ward Pharmaceuticals
- Mylan
Highlights of The Naloxone Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Spray forms
- Injectable forms
- By Application:
- Opioid overdose
- Preventing opioid abuse
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Naloxone Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Naloxone is a medication that can reverse the effects of an opioid overdose. It is available as a nasal spray or injection.
Some of the major players in the naloxone market are ADAPT Pharma, Amphastar Pharmaceuticals, Pfizer, kaleo, Sandoz, Amneal Pharmaceuticals, West Ward Pharmaceuticals, Mylan.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Naloxone Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Naloxone Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Naloxone Market - Supply Chain
4.5. Global Naloxone Market Forecast
4.5.1. Naloxone Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Naloxone Market Size (000 Units) and Y-o-Y Growth
4.5.3. Naloxone Market Absolute $ Opportunity
5. Global Naloxone Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Naloxone Market Size and Volume Forecast by Type
5.3.1. Spray forms
5.3.2. Injectable forms
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Naloxone Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Naloxone Market Size and Volume Forecast by Application
6.3.1. Opioid overdose
6.3.2. Preventing opioid abuse
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Naloxone Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Naloxone Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Naloxone Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Naloxone Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Naloxone Demand Share Forecast, 2019-2026
9. North America Naloxone Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Naloxone Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Naloxone Market Size and Volume Forecast by Application
9.4.1. Opioid overdose
9.4.2. Preventing opioid abuse
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Naloxone Market Size and Volume Forecast by Type
9.7.1. Spray forms
9.7.2. Injectable forms
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Naloxone Demand Share Forecast, 2019-2026
10. Latin America Naloxone Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Naloxone Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Naloxone Market Size and Volume Forecast by Application
10.4.1. Opioid overdose
10.4.2. Preventing opioid abuse
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Naloxone Market Size and Volume Forecast by Type
10.7.1. Spray forms
10.7.2. Injectable forms
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Naloxone Demand Share Forecast, 2019-2026
11. Europe Naloxone Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Naloxone Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Naloxone Market Size and Volume Forecast by Application
11.4.1. Opioid overdose
11.4.2. Preventing opioid abuse
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Naloxone Market Size and Volume Forecast by Type
11.7.1. Spray forms
11.7.2. Injectable forms
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Naloxone Demand Share, 2019-2026
12. Asia Pacific Naloxone Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Naloxone Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Naloxone Market Size and Volume Forecast by Application
12.4.1. Opioid overdose
12.4.2. Preventing opioid abuse
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Naloxone Market Size and Volume Forecast by Type
12.7.1. Spray forms
12.7.2. Injectable forms
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Naloxone Demand Share, 2019-2026
13. Middle East & Africa Naloxone Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Naloxone Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Naloxone Market Size and Volume Forecast by Application
13.4.1. Opioid overdose
13.4.2. Preventing opioid abuse
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Naloxone Market Size and Volume Forecast by Type
13.7.1. Spray forms
13.7.2. Injectable forms
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Naloxone Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Naloxone Market: Market Share Analysis
14.2. Naloxone Distributors and Customers
14.3. Naloxone Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ADAPT Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Amphastar Pharmaceuticals
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. kaleo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sandoz
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Amneal Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. West Ward Pharmaceuticals
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mylan
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
